Survival Analysis of 1140 Patients with Biliary Cancer and Benefit from Concurrent Renin-Angiotensin Antagonists, Statins, or Aspirin with Systemic Therapy.

Valerie Gunchick,Rachel L McDevitt, Elizabeth Choi, Katherine Winslow,Mark M Zalupski,Vaibhav Sahai

The oncologist（2023）

引用 3|浏览5

暂无评分

摘要

In contrast to prior studies, no progression free or overall survival benefit in patients with advanced BTC from concurrent use of ACE-I/ARBs, statin, and/or aspirin with systemic therapy was observed when assessed by BTC subtype or specific systemic therapy regimen.

查看译文

关键词

angiotensin receptor antagonist,angiotensin-converting enzyme inhibitor,aspirin,biliary tract neoplasms,cholangiocarcinoma,statin

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要